Among cohorts of patients with all sub-types of breast cancer, patients with higher expression (the higher quartile of the cohorts) of EIF4EBP1 and LSM1 mRNA had worse Relapse-Free Survival (RFS) than patients with lower expression of either genes, suggesting that the two genes act as oncogenes (Figure 8A and Figure 9A). Here, EIF4EBP1 is linked to breast carcinoma.